-
Article
Clinical practice recommendations for kidney involvement in tuberous sclerosis complex: a consensus statement by the ERKNet Working Group for Autosomal Dominant Structural Kidney Disorders and the ERA Genes & Kidney Working Group
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by the presence of proliferative lesions throughout the body. Management of TSC is challenging because patients have a multiface...
-
Article
Open AccessCharacterization of high-grade prostate cancer at multiparametric MRI: assessment of PI-RADS version 2.1 and version 2 descriptors across 21 readers with varying experience (MULTI study)
To assess PI-RADSv2.1 and PI-RADSv2 descriptors across readers with varying experience.
-
Article
Balancing the benefits and harms of MRI-directed biopsy pathways
• Before a prostate biopsy, the likely benefits and the harms emanating from true and false test MRI results need to be balanced. Prioritizing patients’ preferences and their tolerance to potenti...
-
Article
Open AccessESUR/ESUI position paper: develo** artificial intelligence for precision diagnosis of prostate cancer using magnetic resonance imaging
Artificial intelligence developments are essential to the successful deployment of community-wide, MRI-driven prostate cancer diagnosis. AI systems should ensure that the main benefits of biopsy avoidance are ...
-
Article
Chest CT for rapid triage of patients in multiple emergency departments during COVID-19 epidemic: experience report from a large French university hospital
To assess the diagnostic performances of chest CT for triage of patients in multiple emergency departments during COVID-19 epidemic, in comparison with reverse transcription polymerase chain reaction (RT-PCR) ...
-
Article
Open AccessConsensus statements on PSMA PET/CT response assessment criteria in prostate cancer
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) is used for (re)staging prostate cancer (PCa) and as a biomarker for evaluating response to therapy, but la...
-
Article
Correction to: National dose reference levels in computed tomography–guided interventional procedures—a proposal
The original version of this article, published on 02 May 2020, unfortunately contained a mistake.
-
Article
Open AccessESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists’ training
This study aims to define consensus-based criteria for acquiring and reporting prostate MRI and establishing prerequisites for image quality.
-
Article
Open AccessThe primacy of multiparametric MRI in men with suspected prostate cancer
Multiparametric MRI (mpMRI) became recognised in investigating those with suspected prostate cancer between 2010 and 2012; in the USA, the preventative task force moratorium on PSA screening was a strong catal...
-
Article
Open AccessInternational Society for Therapeutic Ultrasound Conference 2016
-
Article
Open AccessExternal beam radiation therapy or high intensity focused ultrasound for localized prostate cancer: a matched pair analysis in the prostate-specific antigen era
-
Article
Open AccessFocal treatment of prostate cancer using Focal One device: pilot study results
-
Article
Open AccessRadical prostatectomy versushigh intensity focused ultrasound for localized prostate cancer: a matched pair comparison
-
Article
Open AccessSafety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study)
To prospectively compare the renal safety of meglumine gadoterate (Gd-DOTA)-enhanced magnetic resonance imaging (MRI) to a control group (unenhanced MRI) in high-risk patients.
-
Article
Open AccessESUR prostate MR guidelines 2012
The aim was to develop clinical guidelines for multi-parametric MRI of the prostate by a group of prostate MRI experts from the European Society of Urogenital Radiology (ESUR), based on literature evidence and...
-
Article
Traitement par ultrasons focalisés du cancer localisé de la prostate: Résultats carcinologiques et pronostic sexuel
Evaluer l’efficacité du traitement du cancer localisé de la prostate par ultrasons focalisés de haute intensité (HIFU), et son retentissement sur la fonction sexuelle.